ASAM Provider Guide

National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update

ASAM Opioid Addiction Treatment GUIDELINES Apps and Pocket Guides brought to you courtesy of Guideline Central. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1224390

Contents of this Issue

Navigation

Page 18 of 29

19 Cassipa (sublingual film) Generic equiv. of Subutex (sublingual tablet) Sublocade b (subcutaneous injection) Brixadi (IM or deep SC injection) 2mg bup tablet Two 2mg bup tablets One 8mg bup tablet 100mg 16mg SC bup weekly injection; or 64mg SC bup monthly injection 12mg bup (Taken as: One and a half 8mg bup tablets or one 8mg bup tablets plus two 2mg bup tablets) 16mg bup/4mg nal c 16mg bup (Taken as: Two 8mg bup tablets) 24mg SC bup weekly injection; or 96mg SC bup monthly injection 24mg bup (Taken as: ree 8mg bup tablets) 300mg 32mg SC bup weekly injection; or 128mg SC bup monthly injection

Articles in this issue

Archives of this issue

view archives of ASAM Provider Guide - National Practice Guideline for the Treatment of Opioid Use Disorder - 2020 Update